Recipient (identified below) is requesting access to SchizConnect for the purpose of scientific investigation, teaching or the planning of clinical research studies. Prior to accessing the SchizConnect data ("Data"), Recipient must agree to the following terms and conditions regarding its use:

• Recipient will receive access to de-identified Data which are to be used at Recipient’s own risk.  The Data are provided "as is" and no warranties are provided, express or implied, regarding the Data, its merchantability or fitness for a particular purpose, its use by Recipient or any product or process based thereon. 


• Recipient agrees that the Data should not be redistributed to third parties unless such third parties have agreed in writing to the terms and conditions contained herein prior to transfer.  Recipient agrees that appropriate safeguards are in place to ensure that the Data is not used or disclosed in a manner inconsistent with the terms of this agreement. Recipient agrees to report any unauthorized use of the Data within fifteen (15) days of Recipient becoming aware of such unauthorized use or disclosure.


• Recipient will make no attempt to determine the identity of any individual who contributed to these Data, except as permitted by law.
  


• Recipient agrees to obtain any necessary approvals or permissions which may be required by its institutional review board or human subjects protections office regarding the use of SchizConnect Data.
  
  
• Recipient will cite SchizConnect as the source of the Data, and the SchizConnect funding source (1U01 MH097435) as scientifically appropriate or customary in any abstract, publication or public disclosure reporting Recipient’s use of the Data in order to accurately acknowledge the contributions of SchizConnect personnel. Depending upon the length and focus of the article, it may be appropriate to include more or less than the example below, however, inclusion of some variation of the language shown below is mandatory:


• "Data used in preparation of this article were obtained from the SchizConnect database (http://schizconnect.org) As such, the investigators within SchizConnect contributed to the design and implementation of SchizConnect and/or provided data but did not participate in analysis or writing of this report."


• Recipient will acknowledge funding by SchizConnect in the support acknowledgement section of the manuscript using language similar to the following:


• "Data collection and sharing for this project was funded by NIMH cooperative agreement 1U01 MH097435."
• It is the policy of SchizConnect to make Data available to investigators as quickly as possible. However, data analysis for this project is expected to evolve as methods and procedures develop over time. Therefore, Recipient acknowledges that any Data downloaded by Recipient may be preliminary and that results may change as new methods of analysis are implemented. Recipient should ensure it is using the most recent Data available, prior to publication.


• Recipient understands that failure to abide by these terms and conditions will result in termination of its privileges to access SchizConnect Data.

Revised October 2014

Please agree to include the acknowledgment and cite the article below in any manuscript in which the COBRE data is used.

Acknowledgement: Data was downloaded from the COllaborative Informatics and Neuroimaging Suite Data Exchange tool (COINS;http://coins.mrn.org/dx) and data collection was funded by NIMH R01MH084898-01A1,

“Brain Glutamate and Outcome in Schizophrenia”, PI: J. Bustillo Bustillo JR, et al, Glutamatergic and neuronal dysfunction in gray and white matter: a spectroscopic imaging study in a large schizophrenia sample Schizophr Bull. 2016 Aug 22. PubMed PMID: 27550776.

Please agree to include the acknowledgment and cite the article below in any manuscript in which the COBRE data is used.

Acknowledgement: Data was downloaded from the COllaborative Informatics and Neuroimaging Suite Data Exchange tool (COINS; http://coins.mrn.org/dx) and data collection was performed at the Mind Research Network, and funded by a Center of Biomedical Research Excellence (COBRE) grant 5P20RR021938/P20GM103472 from the NIH to Dr. Vince Calhoun.

C. Aine, H. J. Bockholt, J. Bustillo, J. Canive, A. Caprihan, C. Gasparovic, F. M. Hanlon, J. Houck, R. Jung, J. Lauriello, J. Liu, A. Mayer, N. Perrone-Bizzozero, S. Posse, J. Stephen, J. Turner, V. Clark, and V. D. Calhoun, "Multimodal Imaging in Schizophrenia: Description and Dissemination," NeuroInformatics, in press. https://www.ncbi.nlm.nih.gov/pubmed/28812221

I request access to data collected by the Mind Clinical Imaging Consortium (MCIC) for the purpose of scientific investigation, teaching or the planning of clinical research studies and agree to the following terms:

1. I will receive access to de-identified data and will not attempt to establish the identity of, or attempt to contact any of the MCIC participants.

2. I will not further disclose these data beyond the uses outlined in this agreement and my data use application.

3. I will require anyone on my team who utilizes these data, or anyone with whom I share these data to comply with this data use agreement.

4. I will comply with any rules and regulations imposed by my institution and its institutional review board in requesting these data.

5. I will ensure that Investigators who utilize MCIC data use appropriate administrative, physical and technical safeguards to prevent use or disclosure of the data other than as provided for by this Agreement.

6. I will report any use or disclosure of the data not provided for by this Agreement of which I become aware within 15 days of becoming aware of such use or disclosure. Reports/disclosures should be sent via email to Jody Roberts, Director of Research and Clinical Operations at MRN, jroberts@mrn.org

If I publish abstracts or manuscripts using data from MCIC, I agree to the following:

7. I will cite MCIC as the source of data and the DOE funding source in the publication as space allows. Ex: "The imaging data and demographic information was collected and shared by [University of Iowa, University of Minnesota, University of New Mexico, Massachusetts General Hospital] the Mind Research Network supported by the Department of Energy under Award Number DE-FG02-08ER64581."

8. I will cite Gollub, RL, et al “The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia” Neuroinformatics, 2013 in all reports based on these data, as appropriate.

9. I will include language similar to the following in the methods section of my manuscripts in order to accurately acknowledge data gathering by the MCIC investigators. Depending upon the length and focus of the article, it may be appropriate to include more or less than the example below, however, inclusion of some variation of the language shown below is mandatory. "Data used in the preparation of this work were obtained from the Mind Clinical Imaging Consortium database through the Mind Research Network (www.mrn.org). The MCIC project was supported by the Department of Energy under Award Number DE-FG02-08ER64581. MCIC is the result of efforts of co-investigators from University of Iowa, University of Minnesota, University of New Mexico, Massachusetts General Hospital.

I understand that failure to abide by these guidelines will result in termination of my privileges to access MCIC data.

Recipient (identified below) is requesting access to the Neuromorphometry by Computer Algorithm Chicago (NMorphCH) dataset for the purpose of scientific investigation, teaching or the planning of clinical research studies. Prior to accessing the NMorphCH data ("Data"), Recipient must agree to the following terms and conditions regarding its use:

• Recipient will receive access to de-identified Data which are to be used at Recipient’s own risk. The Data are provided "as is" and Northwestern University makes no warranties, express or implied, regarding the Data, its merchantability or fitness for a particular purpose, its use by Recipient or any product or process based thereon. 


• Recipient will make no attempt to determine the identity of any individual who contributed to these Data.
• Recipient will cite NMorphCH as the source of Data, and the NMorphCH funding source (R01 MH056584) in the abstract as space allows.


• Recipient will include appropriate acknowledgement of the source of the Data in any manuscripts or publications reporting its use in order to accurately acknowledge the contributions of NMorphCH personnel. Depending upon the length and focus of the article, it may be appropriate to include more or less than the example below, however, inclusion of some variation of the language shown below is mandatory:


• "Data used in preparation of this article were obtained from the Neuromorphometry by Computer Algorithm Chicago (NMorphCH) dataset (http://nunda.northwestern.edu/nunda/data/projects/NMorphCH) As such, the investigators within NMorphCH contributed to the design and implementation of NMorphCH and/or provided data but did not participate in analysis or writing of this report."

• Recipient will acknowledge funding by NMorphCH in the support acknowledgement section of the manuscript using language similar to the following:


• "Data collection and sharing for this project was funded by NIMH grant R01 MH056584."

• It is the policy of NMorphCH to make Data available to investigators as quickly as possible. However, data analysis for this project is expected to evolve as methods and procedures develop over time. Therefore, Recipient acknowledges that any Data downloaded by Recipient may be preliminary and that results may change as new methods of analysis are implemented. Recipient should ensure it is using the most recent Data available, prior to publication.


• Recipient agrees that the Data should not be redistributed to third parties unless such third parties have agreed in writing to the terms and conditions contained herein prior to transfer.


• Recipient understands that failure to abide by these terms and conditions will result in termination of its privileges to access NMorphCH Data.

Revised September 2016

Recipient (identified below) is requesting access to Northwestern University Schizophrenia Data and Software Tool for the purpose of scientific investigation, teaching or the planning of clinical research studies. Prior to accessing the NUSDAST data ("Data"), Recipient must agree to the following terms and conditions regarding its use:

• Recipient acknowledges that it may also request data access on XNAT Central.


• Recipient will receive access to de-identified Data which are to be used at Recipient’s own risk.  The Data are provided "as is" and Northwestern University makes no warranties, express or implied, regarding the Data, its merchantability or fitness for a particular purpose, its use by Recipient or any product or process based thereon. 


• Recipient will make no attempt to determine the identity of any individual who contributed to these Data.
• Recipient will cite NUSDAST as the source of Data, and the NUSDAST funding source (1R01 MH084803) in the abstract as space allows.


• Recipient will include appropriate acknowledgement of the source of the Data in any manuscripts or publications reporting its use in order to accurately acknowledge the contributions of NUSDAST personnel. Depending upon the length and focus of the article, it may be appropriate to include more or less than the example below, however, inclusion of some variation of the language shown below is mandatory:


• "Data used in preparation of this article were obtained from the NU Schizophrenia Data and Software Tool (NUSDAST) database (http://central.xnat.org/REST/projects/NUDataSharing) As such, the investigators within NUSDAST contributed to the design and implementation of NUSDAST and/or provided data but did not participate in analysis or writing of this report."

• Recipient will acknowledge funding by NUSDAST in the support acknowledgement section of the manuscript using language similar to the following:


• "Data collection and sharing for this project was funded by NIMH grant 1R01 MH084803."

• Recipient agrees to provide a bibliographic citation of the final published presentation or article for inclusion in the NUSDAST literature archive. Recipient will send this information to leiwang1@northwestern.edu


• It is the policy of NUSDAST to make Data available to investigators as quickly as possible. However, data analysis for this project is expected to evolve as methods and procedures develop over time. Therefore, Recipient acknowledges that any Data downloaded by Recipient may be preliminary and that results may change as new methods of analysis are implemented. Recipient should ensure it is using the most recent Data available, prior to publication.


• Recipient agrees that the Data should not be redistributed to third parties unless such third parties have agreed in writing to the terms and conditions contained herein prior to transfer.


• Recipient understands that failure to abide by these terms and conditions will result in termination of its privileges to access NUSDAST Data.

Revised October 2014

Recipient (identified below) is requesting access to the REWARD dataset for the purpose of scientific investigation, teaching or the planning of clinical research studies. Prior to accessing the REWARD data ("Data"), Recipient must agree to the following terms and conditions regarding its use:

• Recipient will receive access to de-identified Data which are to be used at Recipient’s own risk. The Data are provided "as is" and Washington University in St. Louis makes no warranties, express or implied, regarding the Data, its merchantability or fitness for a particular purpose, its use by Recipient or any product or process based thereon. 


• Recipient will make no attempt to determine the identity of any individual who contributed to these Data.
• Recipient will cite REWARD as the source of Data, and the REWARD funding source (NIMH MH066031) in abstracts for submission and the methods sections of papers.


• Recipient will include appropriate acknowledgement of the source of the Data in any manuscripts or publications reporting its use in order to accurately acknowledge the contributions of REWARD personnel. Depending upon the length and focus of the article, it may be appropriate to include more or less than the example below, however, inclusion of some variation of the language shown below is mandatory:
  
  
  • "Data used in preparation of this article were obtained from the REWARD dataset. As such, the investigators within REWARD contributed to the design and implementation of REWARD and/or provided data but did not participate in analysis or writing of this report."
  
  
• Recipient will acknowledge funding by REWARD in the support acknowledgement section of the manuscript using language similar to the following:
  
  
  • "Data collection and sharing for this project was funded by NIMH grant MH066031."
  
  
• It is the policy of REWARD to make Data available to investigators as quickly as possible. However, data analysis for this project is expected to evolve as methods and procedures develop over time. Therefore, Recipient acknowledges that any Data downloaded by Recipient may be preliminary and that results may change as new methods of analysis are implemented. Recipient should ensure it is using the most recent Data available, prior to publication.


• Recipient agrees that the Data should not be redistributed to third parties unless such third parties have agreed in writing to the terms and conditions contained herein prior to transfer.


• Recipient understands that failure to abide by these terms and conditions will result in termination of its privileges to access REWARD Data.

Revised November 2017